CRP and atherosclerosis: Indeed, there is growing evidence that proinflammatory cytokines, such as IL-1, IL-6, TNF-α and CRP, contribute to atherosclerosis and adverse cardiovascular outcomes and predict mortality in ESRD patients [14–17].